|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Hepatitis B virus (HBV) infection continues to be a serious public health problem globally. The seroprevalence of Hepatitis B surface antigen among patients attending a tertiary care hospital is useful in assessing true nature of problem, which can help to estimate the magnitude of HBV infection and aid in devising preventive measures. The present study was done to evaluate the seroprevalence of hepatitis B surface antigen among patients attending a tertiary care hospital. The present study was carried out in Department of Microbiology, at a tertiary care hospital, from Jan 2013 to Dec 2018. A total of 57256 patients were included in the study whose venous blood samples were collected, and serum was tested for the presence of HBsAg using a rapid one step chromatographic immunoassay test kit (OSCAR Laboratories Pvt. Ltd. Delhi). Out of 57256 patients whose blood samples were tested, 1089 were found to be positive for HBsAg giving the prevalence rate as 1.90%, with 602(2.86%) males and 487(1.34%) females. The majority of the positive patients belonged to age group 21-40 years (2.11%). The present study shows seroprevalence rate of HBsAg is 1.90% in economically productive groups. This type of study can be an alternative option for community based studies to formulate strategies for its control and prevention.